𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum metabolomic profile and potential biomarkers for severity of fibrosis in nonalcoholic fatty liver disease

✍ Scribed by Katsutoshi Tokushige, Etsuko Hashimoto, Kazuhisa Kodama…

Book ID
120914531
Publisher
Springer Japan
Year
2013
Tongue
English
Weight
580 KB
Volume
48
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum M30 levels: A potential biomarker
Serum M30 levels: A potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels
✍ Yusuf Yilmaz; Engin Ulukaya; Enver Dolar 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 2 views

We congratulate Fracanzani and colleagues 1 on their insightful article identifying factors associated with severe liver disease in patients with nonalcoholic fatty liver disease (NAFLD) and normal aminotransferase levels. First, the authors have convincingly demonstrated that normal alanine aminotr

Serum ferritin is an independent predict
Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease
✍ Kris V. Kowdley; Patricia Belt; Laura A. Wilson; Matthew M. Yeh; Brent A. Neusch 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB 👁 2 views

Serum ferritin (SF) levels are commonly elevated in patients with nonalcoholic fatty liver disease (NAFLD) because of systemic inflammation, increased iron stores, or both. The aim of this study was to examine the relationship between elevated SF and NAFLD severity. Demographic, clinical, histologic

Increased fructose consumption is associ
Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease
✍ Manal F. Abdelmalek; Ayako Suzuki; Cynthia Guy; Aynur Unalp-Arida; Ryan Colvin; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 1 views

The rising incidence of obesity and diabetes coincides with a marked increase in fructose consumption. Fructose consumption is higher in individuals with nonalcoholic fatty liver disease (NAFLD) than in age-matched and body mass index (BMI)-matched controls. Because fructose elicits metabolic pertur